Investigación / Grupos de investigación

Grupo  602

Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Publicaciones (902)

  • Martin, AJM; Ortega, I; Font, C; Pachon, V; Castellon, V; Martinez-Marin, V; Salgado, M; Martinez, E; Calzas, J; Ruperez, A; Souto, JC; Martin, M; Salas, E; Soria, JM.

    Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer

    BRITISH JOURNAL OF CANCER. 2018; 118(8): 1056-1061 Nº de citas: 108 [doi:10.1038/s41416-018-0027-8]

  • Calvo-Ferrandiz, E; Peraita-Adrados, R.

    Narcolepsy with cataplexy and pregnancy: a case-control study

    JOURNAL OF SLEEP RESEARCH. 2018; 27(2): 268-272 Nº de citas: 22 [doi:10.1111/jsr.12567]

  • Rugo, HS; Dieras, V; Gelmon, KA; Finn, RS; Slamon, DJ; Martin, M; Neven, P; Shparyk, Y; Mori, A; Lu, DR; Bhattacharyya, H; Bartlett, CH; Iyer, S; Johnston, S; Ettl, J; Harbeck, N.

    Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trial

    ANNALS OF ONCOLOGY. 2018; 29(4): 888-894 Nº de citas: 129 [doi:10.1093/annonc/mdy012]

  • Garrido, P; Aldaz, A; Vera, R; Calleja, MA; de Alava, E; Martin, M; Matias-Guiu, X; Palacios, J.

    Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFH

    Clinical & Translational Oncology. 2018; 20(4): 443-447 Nº de citas: 18 [doi:10.1007/s12094-017-1740-0]

  • Di Leo, A; Jerusalem, G; Torres, R; Verhoeven, D; Pendergrass, K; Malorni, L; Lichfield, J; Martin, M.

    First-line vs second-line fulvestrant for hormone receptor-positive advanced breast cancer: A post-hoc analysis of the CONFIRM study

    BREAST. 2018; 38: 144-149 Nº de citas: 12 [doi:10.1016/j.breast.2017.12.016]

  • Hanna, GJ; Busaidy, NL; Chau, NG; Wirth, LJ; Barletta, JA; Calles, A; Haddad, RI; Kraft, S; Cabanillas, ME; Rabinowits, G; O'Neill, A; Limaye, SA; Alexander, EK; Moore, FD; Misiwkeiwicz, K; Thomas, T; Nehs, M; Marqusee, E; Lee, SL; Janne, PA; Lorch, JH.

    Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study

    CLINICAL CANCER RESEARCH. 2018; 24(7): 1546-1553 Nº de citas: 101 [doi:10.1158/1078-0432.CCR-17-2297]

  • Samaniego, R; Gutierrez-Gonzalez, A; Gutierrez-Seijo, A; Sanchez-Gregorio, S; Garcia-Gimenez, J; Mercader, E; Marquez-Rodas, I; Aviles, JA; Relloso, M; Sanchez-Mateos, P.

    CCL20 Expression by Tumor-Associated Macrophages Predicts Progression of Human Primary Cutaneous Melanoma

    Cancer Immunology Research. 2018; 6(3): 267-275 Nº de citas: 66 [doi:10.1158/2326-6066.CIR-17-0198]

  • Turner, NC; Finn, RS; Martin, M; Im, SA; DeMichele, A; Ettl, J; Dieras, V; Moulder, S; Lipatov, O; Colleoni, M; Cristofanilli, M; Lu, DR; Mori, A; Giorgetti, C; Iyer, S; Bartlett, CH; Gelmon, KA.

    Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastases

    ANNALS OF ONCOLOGY. 2018; 29(3): 669-680 Nº de citas: 81 [doi:10.1093/annonc/mdx797]

  • Grothey, A; Yoshino, T; Bodoky, G; Ciuleanu, T; Garcia-Carbonero, R; Garcia-Alfonso, P; Van Cutsem, E; Muro, K; Mytelka, DS; Li, L; Lipkovich, O; Hsu, Y; Sashegyi, A; Ferry, D; Nasroulah, F; Tabernero, J.

    Association of baseline absolute neutrophil counts and survival in patients with metastatic colorectal cancer treated with second-line antiangiogenic therapies: exploratory analyses of the RAISE trial and validation in an electronic medical record data set

    ESMO Open. 2018; 3(3): Nº de citas: 17 [doi:10.1136/esmoopen-2018-000347]

  • Abad, A; Martinez-Balibrea, E; Vieitez, JM; Alonso-Orduna, V; Alfonso, PG; Manzano, JL; Massuti, B; Benavides, M; Carrato, A; Zanui, M; Gallego, J; Gravalos, C; Conde, V; Provencio, M; Valladares-Ayerbes, M; Salazar, R; Sastre, J; Montagut, C; Rivera, F; Aranda, E.

    Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trial

    ANNALS OF ONCOLOGY. 2018; 29(2): 439-444 Nº de citas: 9 [doi:10.1093/annonc/mdx737]

  • Alsina, M; Rivera, F; Ramos, FJ; Galan, M; Lopez, R; Garcia-Alfonso, P; Ales-Martinez, JE; Queralt, B; Anton, A; Carrato, A; Gravalos, C; Mendez-Vidal, MJ; Lopez, C; de Mena, IR; Tabernero, J; Giralt, J; Aranda, E; GICOR.

    A phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients

    Targeted Oncology. 2018; 13(1): 69-78 Nº de citas: 3 [doi:10.1007/s11523-017-0536-z]

  • Karachaliou, N; Gonzalez-Cao, M; Crespo, G; Drozdowskyj, A; Aldeguer, E; Gimenez-Capitan, A; Teixido, C; Molina-Vila, MA; Viteri, S; Gil, MD; Algarra, SM; Perez-Ruiz, E; Marquez-Rodas, I; Rodriguez-Abreu, D; Blanco, R; Puertolas, T; Royo, MA; Rosell, R.

    Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients

    Therapeutic Advances in Medical Oncology. 2018; 10: Nº de citas: 208 [doi:10.1177/1758834017749748]

  • Garcia-Gonzalez, X; Lopez-Tarruella, S; Garcia, MI; Gonzalez-Haba, E; Blanco, C; Salvador-Martin, S; Jerez, Y; Thomas, F; Jarama, M; Saez, MS; Martin, M; Lopez-Fernandez, LA.

    Severe toxicity to capecitabine due to a new variant at a donor splicing site in the dihydropyrimidine dehydrogenase (DPYD) gene

    Cancer Management and Research. 2018; 10: 4517-4522 Nº de citas: 6 [doi:10.2147/CMAR.S174470]

  • Carmona-Bayonas, A; Jimenez-Fonseca, P; Custodio, A; Canovas, MS; Hernandez, R; Pericay, C; Echavarria, I; Lacalle, A; Visa, L; Palomo, AR; Mangas, M; Cano, JM; Buxo, E; Alvarez-Mancenido, F; Garcia, T; Lorenzo, JE; Ferrer-Cardona, M; Viudez, A; Azkarate, A; Ramchandani, A; Arias, D; Longo, F; Lopez, C; Bayona, RS; Limon, ML; Diaz-Serrano, A; Montes, AF; Sala, P; Cerda, P; Rivera, F; Gallego, J.

    Anthracycline-based triplets do not improve the efficacy of platinum-fluoropyrimidine doublets in first-line treatment of advanced gastric cancer: real-world data from the AGAMEMON National Cancer Registry

    Gastric Cancer. 2018; 21(1): 96-105 Nº de citas: 18 [doi:10.1007/s10120-017-0718-5]

  • Alberro, JA; Ballester, B; Deulofeu, P; Fabregas, R; Fraile, M; Gubern, JM; Janer, J; Moral, A; de Pablo, JL; Penalva, G; Puig, P; Ramos, M; Rojo, R; Santesteban, P; Serra, C; Sola, M; Solarnau, L; Solsona, J; Veloso, E; Vidal, S; Abe, O; Abe, R; Enomoto, K; Kikuchi, K; Koyama, H; Masuda, H; Nomura, Y; Ohashi, Y; Sakai, K; Sugimachi, K; Toi, M; Tominaga, T; Uchino, J; Yoshida, M; Coles, CE; Haybittle, JL; Mobus, V; Leonard, CF; Calais, G; Garaud, P; Collett, V; Davies, C; Delmestri, A; Sayer, J; Harvey, VJ; Holdaway, IM; Kay, RG; Mason, BH; Forbe, JF; Franci, PA; Wilcken, N; Balic, M; Bartsch, R; Fesl, C; Fitzal, F; Fohler, H; Gnant, M; Greil, R; Jakesz, R; Marth, C; Mlineritsch, B; Pfeiler, G; Singer, CF; Steger, GG; Stoger, H; Canney, P; Yosef, HMA; Focan, C; Peek, U; Oates, GD; Powell, J; Durand, M; Mauriac, L; Di Leo, A; Dolci, S; Larsimont, D; Nogaret, JM; Philippson, C; Piccart, MJ; Masood, MB; Parker, D; Price, JJ; Lindsay, MA; Mackey, J; Martin, M; Hupperets, PSGJ; Bates, T; Blamey, RW; Chetty, U; Ellis, IO; Mallon, E; Morgan, DAL; Patnick, J; Pinder, S; Lohrisch, C; Nichol, A; Bartlett, JMS; Bramwell, VH; Chen, BE; Chia, SKL; Gelmon, K; Goss, PE; Levine, MN; Parulekar, W; Pater, JL; Pritchard, KI; Shepherd, LE; Tu, D; Whelan, T; Berry, D; Broadwater, G; Cirrincione, C; Muss, H; Norton, L; Weiss, RB; Abu-Zahara, HT; Karpov, A; Portnoj, SL; Bowden, S; Brookes, C; Dunn, J; Fernando, I; Lee, M; Poole, C; Rea, D; Spooner, D; Barrett-Lee, PJ; Manse, RE; Monypenny, IJ; Gordon, NH; Davis, HL; Cuzick, J; Sestak, I; Lehingue, Y; Romestaing, P; Dubois, JB; Delozier, T; Griffon, B; Lesec'H, JM; Mustacchi, G; Petruzelka, L; Pribylova, O; Owen, JR; Meier, P; Shan, Y; Shao, YF; Wang, X; Zhao, DB; Howell, A; Swindell, R; Albano, J; de Oliveira, CF; Gervasio, H; Gordilho, J; Ejlertsen, B; Jensen, MB; Mouridsen, H; Gelman, RS; Harris, JR; Hayes, D; Henderson, C; Shapiro, CL; Christiansen, P; Ejlertsen, B; Ewertz, M; Jensen, MB; Mouridsen, HT; Fehm, T; Trampisch, HJ; Dalesio, O; de Vries, EGE; Rodenhuis, S; van Tinteren, H; Comis, RL; Davidson, NE; Gray, R; Robert, N; Sledge, G; Solin, LJ; Sparano, JA; Tormey, DC; Wood, W; Cameron, D; Chetty, U; Dixon, JM; Forrest, P; Jack, W; Kunkler, I; Rossbach, J; Klijn, JGM; Treurniet-Donker, AD; van Putten, WLJ; Rotmensz, N; Veronesi, U; Viale, G; Bartelink, H; Bijker, N; Bogaerts, J; Cardoso, F; Cufer, T; Julien, JP; Poortmans, PM; Rutgers, E; van de Velde, CJH; Cunningham, MP; Huovinen, R; Joensuu, H; Costa, A; Bonadonna, G; Gianni, L; Valagussa, P; Goldstein, LJ; Bonneterre, J; Fargeot, P; Fumoleau, P; Kerbrat, P; Lupors, E; Namer, M; Carrasco, E; Martin, M; Segui, MA; Eierman, W; Hilfrich, J; Jonat, W; Kaufmann, M; Kreienberg, R; Schumacher, M; Bastert, G; Rauschecker, H; Sauer, R; Sauerbrei, W; Schauer, A; Schumacher, M; Blohmer, JU; Costa, SD; Eidtmann, H; Gerber, B; Jackisch, C; Loib, S; von Minckwitz, G; de Schryver, A; Vakaet, L; Belfiglio, M; Nicolucci, A; Pellegrini, F; Pirozzoli, MC; Sacco, M; Valentini, M; McArdle, CS; Smith, DC; Stallard, S; Dent, DM; Gudgeon, CA; Hacking, A; Murray, E; Panieri, E; Werner, ID; De Salvo, GL; Del Bianco, P; Zavagno, G; Leone, B; Vallejo, CT; Zwenger, A; Galligioni, E; Lopez, M; Erazo, A; Medina, JY; Horiguchi, J; Takei, H; Fentiman, IS; Hayward, JL; Rubens, RD; Skilton, D; Scheurlen, H; Kaufmann, M; Sohn, HC; Untch, M; Dafni, U; Markopoulos, C; Bamia, C; Fountzilas, G; Koliou, GA; Manousou, K; Mavroudis, D; Klefstrom, P; Blomqvist, C; Saarto, T; Gallen, M; Canavese, G; Tinterri, C; Margreiter, R; de Lafontan, B; Mihura, J; Roche, H; Asselain, B; Salmon, RJ; Vilcoq, JR; Brain, E; de La Lande, B; Mouret-Fourme, E; Andre, F; Arriagada, R; Delaloge, S; Hill, C; Koscienly, S; Michiels, S; Rubino, C; A'Hern, R; Bliss, J; Ellis, P; Kilburn, L; Yarnold, JR; Martin, M; Benraadt, J; Kooi, M; van de Velde, AO; van Dongen, JA; Vermorken, JB; Castiglione, M; Coates, A; Colleoni, M; Collins, J; Forbes, J; Gelbe, RD; Goldhirsch, A; Lindtner, J; Price, KN; Regan, MM; Rudenstam, CM; Senn, HJ; Thuerlimann, B; Bliss, JM; Chilvers, CED; Coombes, RC; Hall, E; Marty, M; Buyse, M; Possinger, K; Schmid, P; Untch, M; Wallwiener, D; Foster, L; George, WD; Stewart, HJ; Stroner, P; Borovik, R; Hayat, H; Inbar, MJ; Peretz, T; Robinson, E; Camerini, T; Formelli, F; Martelli, G; Di Mauro, MG; Valagussa, P; Perrone, F; Amadori, D; Martoni, A; Pannuti, F; Camisa, R; Musolino, A; Passalacqua, R; Iwata, H; Shien, T; Abe, O; Ikeda, T; Inokuchi, K; Kikuchi, K; Sawa, K; Sonoo, H; Sadoon, M; Tulusan, AH; Kohno, N; Miyashita, M; Takao, S; Ahn, JH; Jung, KH; Korzeniowski, S; Skolyszewski, J; Ogawa, M; Yamashita, J; Bastiaannet, E; Liefers, GJ; van de Velde, CJH; Christiaens, R; Neven, P; Paridaens, R; Van den Bogaert, W; Gazet, JC; Corcoran, N; Deshpande, N; di Martino, L; Douglas, P; Hacking, A; Host, H; Lindtner, A; Notter, G; Bryant, AJS; Ewing, GH; Firth, LA; Krushen-Kosloski, JL; Nissen-Meyer, R; Anderson, H; Killander, F; Malmstrom, P; Ryden, L; Arnesson, LG; Carstense, J; Dufmats, M; Fohlin, H; Nordenskjold, B; Soderberg, M; Sundqvist, M; Carpenter, TJ; Murray, N; Royle, GT; Simmonds, PD; Albain, K; Barlow, W; Crowley, J; Hayes, D; Gralow, J; Hortobagyi, G; Livingston, R; Martino, S; Osborne, CK; Ravdin, PM; Bergh, J; Bondesso, T; Celebiogl, F; Dahlberg, K; Fornander, T; Fredriksson, I; Frisell, J; Goransson, E; Iiristo, M; Johansson, U; Lenner, E; Lofgren, L; Nikolaidis, P; Perbeck, L; Rotstein, S; Sandelin, K; Skoog, L; Svane, G; af Trampe, E; Wadstrom, C; Janni, W; Castiglione, M; Goldhirsch, A; Maibach, R; Senn, HJ; Thurlimann, B; Bartlett, JMS; Bastiaannet, E; Hadji, P; Hozumi, J; Rea, D; van de Velde, CJH; Holli, K; Rouhento, K; Safra, T; Brenner, H; Hercbergs, A; Yoshimoto, M; Paterson, AHG; Pritchard, KI; Fyles, A; Meakin, JW; Panzarella, T; Pritchard, KI; Bahi, J; Delaloge, S; Lemonnier, J; Martin, AL; Reid, M; Spittle, M; Bishop, H; Bundred, NJ; Cuzick, J; Ellis, IO; Fentiman, IS; Forbes, JF; Forsyth, S; George, WS; Pinder, SE; Sestak, I; Deutsch, GP; Gray, R; Kwong, DLW; Pai, VR; Peto, R; Senanayake, F; Boccardo, F; Rubagotti, A; Baum, M; Forsyth, S; Hackshaw, A; Houghton, J; Ledermann, J; Monson, K; Tobias, JS; Carlomagno, C; De Laurentiis, M; De Placido, S; Schem, C; Williams, L; Bell, R; Cameron, D; Coleman, RE; Dodwell, D; Hinsley, S; Marshall, HC; Hayes, D; Pierce, LJ; Basso, SMM; Lumachi, F; Solomayer, E; Coleman, RE; Horsman, JM; Lester, J; Winter, MC; Buzdar, AU; Hsu, L; Love, RR; Ahlgren, J; Garmo, H; Holmberg, L; Lindman, H; Warnberg, F; Asmar, L; Jones, SE; Aft, R; Gluz, O; Harbeck, N; Liedtke, C; Nitz, U; Litton, A; Wallgren, A; Karlsson, P; Linderholm, BK; Chlebowski, RT; Caffier, H; Brufsky, AM; Coleman, RE; Llombart, HA; EBCTCG; EBCTCG; GROCTA Trialists.

    Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

    LANCET ONCOLOGY. 2018; 19(1): 27-39 Nº de citas: 932 [doi:10.1016/S1470-2045(17)30777-5]

  • Hurvitz, SA; Martin, M; Symmans, WF; Jung, KH; Huang, CS; Thompson, AM; Harbeck, N; Valero, V; Stroyakovskiy, D; Wildiers, H; Campone, M; Boileau, JF; Beckmann, MW; Afenjar, K; Fresco, R; Helms, HJ; Xu, J; Lin, YG; Sparano, J; Slamon, D.

    Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial

    LANCET ONCOLOGY. 2018; 19(1): 115-126 Nº de citas: 437 [doi:10.1016/S1470-2045(17)30716-7]

  • Cassinello, J; Arranz, JA; Piulats, JM; Sanchez, A; Perez-Valderrama, B; Mellado, B; Climent, MA; Olmos, D; Carles, J; Lazaro, M.

    SEOM clinical guidelines for the treatment of metastatic prostate cancer (2017)

    Clinical & Translational Oncology. 2018; 20(1): 57-68 Nº de citas: 16 [doi:10.1007/s12094-017-1783-2]

  • Berrocal, A; Arance, A; Castellon, VE; de la Cruz, L; Espinosa, E; Cao, MG; Larriba, JLG; Marquez-Rodas, I; Soria, A; Algarra, SM.

    SEOM clinical guideline for the management of malignant melanoma (2017)

    Clinical & Translational Oncology. 2018; 20(1): 69-74 Nº de citas: 12 [doi:10.1007/s12094-017-1768-1]